Patient Navigation-based Tobacco Harm Reduction Program Among Cancer Patients

Patient Navigation-based Tobacco Harm Reduction Program Among Cancer Patients

The purpose of this study is to examine the feasibility and preliminary efficacy of patient navigation to promote linkage to smoking cessation treatments in cancer patients.

The investigators plan to conduct a 2-month 1-arm intervention study that will recruit up to 20 smoking cancer patients at Penn State Cancer Institute. All participants will receive a smoking cessation educational brochure and patient navigation intervention (in-person or by phone) delivered over two months. At the first intervention interview, the patient navigators will educate participants about the benefits of quitting, introduce smoking cessation resources, motivate participants to link with treatment, help participants attend smoking cessation treatments, and assess barriers that prevented them from being able to consider smoking cessation. The cessation treatment resources will be discussed include PennState Health Smoking Cessation Clinic, Pennsylvania Quitline, or visiting their primary care provider (PCP) to discuss cessation, prescription medications, and/or nicotine replacement therapy. A follow-up call will be made 1 month later to further assist and motivate to use tobacco treatment services, and assess interim tobacco treatment engagement outcome. At 2 months after baseline, the final questionnaire will be administered to assess participants' smoking behaviors, engagement in tobacco treatments, and satisfaction with the intervention.

Inclusion Criteria:

• Age: ≥ 18 years of age
• Diagnosis of cancer
• Current cigarette smoker (smoked cigarettes in last 30 days)
• Be able to read and speak English

Exclusion Criteria:

• Age: < 18 years of age
• Unable to read and speak English
• Actively using evidence-based smoking cessation treatments
• Known decisional impairment